Translational research. New findings and potential future applications in pancreatic adenocarcinoma
The current achievements in pancreatic cancer diagnosis and treatment are disappointing for patients and clinicians alike. Still, in the dawn of 2012, most patients are diagnosed at a late stage where cure is not feasible, with the majority going to succumb within the same year of diagnosis. Thus, t...
Gespeichert in:
Veröffentlicht in: | Journal of the Pancreas 2012-03, Vol.13 (2), p.177-179 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 179 |
---|---|
container_issue | 2 |
container_start_page | 177 |
container_title | Journal of the Pancreas |
container_volume | 13 |
creator | Strimpakos, Alexios S Syrigos, Kostas N Saif, Muhammad Wasif |
description | The current achievements in pancreatic cancer diagnosis and treatment are disappointing for patients and clinicians alike. Still, in the dawn of 2012, most patients are diagnosed at a late stage where cure is not feasible, with the majority going to succumb within the same year of diagnosis. Thus, the only hope for early and diagnosis and radical treatment is the invention of diagnostic and prognostic tests which might predict accurately patients who may develop this disease and those who have the most aggressive potential, so clinician adopt the appropriate strategy. In this paper we summarize the findings from the three most interesting research abstract as presented at the 2012 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. In particular, we focus on Abstract #160 which shows the diagnostic utility of microRNA serum profiling in pancreatic cancer patients, on Abstract #201 which suggests a potential prognostic role of transforming growth factor (TGF)-beta pathway in advanced pancreatic cancer, and on Abstract #165 which shows that protein S100A4 might be a new, potentially useful, predictive biomarker of gemcitabine efficacy. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_927832906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>927832906</sourcerecordid><originalsourceid>FETCH-LOGICAL-p210t-97b202253794f1f2129625a0ebdebd5df4045a7701b00ed9665c051bdd91ad413</originalsourceid><addsrcrecordid>eNo1kE9LxDAUxIMg7rr6FSQ3T5WXtGk2R1n8B4te1nN5TV410qYxaRG_vUVXGBgGfjOHOWFroQwUW6X1ip3n_AEgQQGcsZWUFdTKqDWzh4Qh9zj5MWDPE2XCZN9v-DN98c4H58Nb5hgcj-NEYfIL1M3TnIhjjL23v83MfeARg020ZMvRURjtMuTDOOAFO-2wz3R59A17vb877B6L_cvD0-52X0QpYCqMbiVIqUptqk50UkhTS4VArVukXFdBpVBrEC0AOVPXyoISrXNGoKtEuWHXf7sxjZ8z5akZfLbU9xhonHNjpN6W0kC9kFdHcm4Hck1MfsD03fz_Uv4AmyFfMQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>927832906</pqid></control><display><type>article</type><title>Translational research. New findings and potential future applications in pancreatic adenocarcinoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Strimpakos, Alexios S ; Syrigos, Kostas N ; Saif, Muhammad Wasif</creator><creatorcontrib>Strimpakos, Alexios S ; Syrigos, Kostas N ; Saif, Muhammad Wasif</creatorcontrib><description>The current achievements in pancreatic cancer diagnosis and treatment are disappointing for patients and clinicians alike. Still, in the dawn of 2012, most patients are diagnosed at a late stage where cure is not feasible, with the majority going to succumb within the same year of diagnosis. Thus, the only hope for early and diagnosis and radical treatment is the invention of diagnostic and prognostic tests which might predict accurately patients who may develop this disease and those who have the most aggressive potential, so clinician adopt the appropriate strategy. In this paper we summarize the findings from the three most interesting research abstract as presented at the 2012 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. In particular, we focus on Abstract #160 which shows the diagnostic utility of microRNA serum profiling in pancreatic cancer patients, on Abstract #201 which suggests a potential prognostic role of transforming growth factor (TGF)-beta pathway in advanced pancreatic cancer, and on Abstract #165 which shows that protein S100A4 might be a new, potentially useful, predictive biomarker of gemcitabine efficacy.</description><identifier>EISSN: 1590-8577</identifier><identifier>PMID: 22406595</identifier><language>eng</language><publisher>Italy</publisher><subject>Adenocarcinoma - diagnosis ; Adenocarcinoma - metabolism ; Adenocarcinoma - therapy ; Biomarkers, Tumor - metabolism ; Humans ; Pancreatic Neoplasms - diagnosis ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - therapy ; Translational Medical Research - trends</subject><ispartof>Journal of the Pancreas, 2012-03, Vol.13 (2), p.177-179</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22406595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Strimpakos, Alexios S</creatorcontrib><creatorcontrib>Syrigos, Kostas N</creatorcontrib><creatorcontrib>Saif, Muhammad Wasif</creatorcontrib><title>Translational research. New findings and potential future applications in pancreatic adenocarcinoma</title><title>Journal of the Pancreas</title><addtitle>JOP</addtitle><description>The current achievements in pancreatic cancer diagnosis and treatment are disappointing for patients and clinicians alike. Still, in the dawn of 2012, most patients are diagnosed at a late stage where cure is not feasible, with the majority going to succumb within the same year of diagnosis. Thus, the only hope for early and diagnosis and radical treatment is the invention of diagnostic and prognostic tests which might predict accurately patients who may develop this disease and those who have the most aggressive potential, so clinician adopt the appropriate strategy. In this paper we summarize the findings from the three most interesting research abstract as presented at the 2012 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. In particular, we focus on Abstract #160 which shows the diagnostic utility of microRNA serum profiling in pancreatic cancer patients, on Abstract #201 which suggests a potential prognostic role of transforming growth factor (TGF)-beta pathway in advanced pancreatic cancer, and on Abstract #165 which shows that protein S100A4 might be a new, potentially useful, predictive biomarker of gemcitabine efficacy.</description><subject>Adenocarcinoma - diagnosis</subject><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - therapy</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Humans</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Translational Medical Research - trends</subject><issn>1590-8577</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE9LxDAUxIMg7rr6FSQ3T5WXtGk2R1n8B4te1nN5TV410qYxaRG_vUVXGBgGfjOHOWFroQwUW6X1ip3n_AEgQQGcsZWUFdTKqDWzh4Qh9zj5MWDPE2XCZN9v-DN98c4H58Nb5hgcj-NEYfIL1M3TnIhjjL23v83MfeARg020ZMvRURjtMuTDOOAFO-2wz3R59A17vb877B6L_cvD0-52X0QpYCqMbiVIqUptqk50UkhTS4VArVukXFdBpVBrEC0AOVPXyoISrXNGoKtEuWHXf7sxjZ8z5akZfLbU9xhonHNjpN6W0kC9kFdHcm4Hck1MfsD03fz_Uv4AmyFfMQ</recordid><startdate>20120310</startdate><enddate>20120310</enddate><creator>Strimpakos, Alexios S</creator><creator>Syrigos, Kostas N</creator><creator>Saif, Muhammad Wasif</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20120310</creationdate><title>Translational research. New findings and potential future applications in pancreatic adenocarcinoma</title><author>Strimpakos, Alexios S ; Syrigos, Kostas N ; Saif, Muhammad Wasif</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p210t-97b202253794f1f2129625a0ebdebd5df4045a7701b00ed9665c051bdd91ad413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adenocarcinoma - diagnosis</topic><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - therapy</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Humans</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Translational Medical Research - trends</topic><toplevel>online_resources</toplevel><creatorcontrib>Strimpakos, Alexios S</creatorcontrib><creatorcontrib>Syrigos, Kostas N</creatorcontrib><creatorcontrib>Saif, Muhammad Wasif</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Strimpakos, Alexios S</au><au>Syrigos, Kostas N</au><au>Saif, Muhammad Wasif</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Translational research. New findings and potential future applications in pancreatic adenocarcinoma</atitle><jtitle>Journal of the Pancreas</jtitle><addtitle>JOP</addtitle><date>2012-03-10</date><risdate>2012</risdate><volume>13</volume><issue>2</issue><spage>177</spage><epage>179</epage><pages>177-179</pages><eissn>1590-8577</eissn><abstract>The current achievements in pancreatic cancer diagnosis and treatment are disappointing for patients and clinicians alike. Still, in the dawn of 2012, most patients are diagnosed at a late stage where cure is not feasible, with the majority going to succumb within the same year of diagnosis. Thus, the only hope for early and diagnosis and radical treatment is the invention of diagnostic and prognostic tests which might predict accurately patients who may develop this disease and those who have the most aggressive potential, so clinician adopt the appropriate strategy. In this paper we summarize the findings from the three most interesting research abstract as presented at the 2012 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. In particular, we focus on Abstract #160 which shows the diagnostic utility of microRNA serum profiling in pancreatic cancer patients, on Abstract #201 which suggests a potential prognostic role of transforming growth factor (TGF)-beta pathway in advanced pancreatic cancer, and on Abstract #165 which shows that protein S100A4 might be a new, potentially useful, predictive biomarker of gemcitabine efficacy.</abstract><cop>Italy</cop><pmid>22406595</pmid><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1590-8577 |
ispartof | Journal of the Pancreas, 2012-03, Vol.13 (2), p.177-179 |
issn | 1590-8577 |
language | eng |
recordid | cdi_proquest_miscellaneous_927832906 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Adenocarcinoma - diagnosis Adenocarcinoma - metabolism Adenocarcinoma - therapy Biomarkers, Tumor - metabolism Humans Pancreatic Neoplasms - diagnosis Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - therapy Translational Medical Research - trends |
title | Translational research. New findings and potential future applications in pancreatic adenocarcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T08%3A53%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Translational%20research.%20New%20findings%20and%20potential%20future%20applications%20in%20pancreatic%20adenocarcinoma&rft.jtitle=Journal%20of%20the%20Pancreas&rft.au=Strimpakos,%20Alexios%20S&rft.date=2012-03-10&rft.volume=13&rft.issue=2&rft.spage=177&rft.epage=179&rft.pages=177-179&rft.eissn=1590-8577&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E927832906%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=927832906&rft_id=info:pmid/22406595&rfr_iscdi=true |